Prot# RLY5016-207: A Randomized, Double-Blind, Placebo-controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients with Resistant Hypertension and Chronic Kidney Disease: Evaluation of Saf

Project: Research project

StatusActive
Effective start/end date4/24/174/24/20

Funding

  • Relypsa, Inc. (Prot# RLY5016-207)